angina - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced blood flow through coronary arteries due to atherosclerosis, leading to decreased oxygen supply to heart muscle. This imbalance causes myocardial ischemia, which manifests as chest pain or discomfort.

• Secondary mechanism: Coronary artery spasm, which can transiently reduce blood flow. These spasms may occur at rest and lead to similar ischemic symptoms, contributing to the unpredictability of angina attacks.

• Key complication: Persistent or severe ischemia can progress to myocardial infarction, causing irreversible damage to heart tissue, highlighting the urgency in managing angina symptoms effectively to prevent further cardiovascular events.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metoprolol, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Chest tightness radiating to left arm, shortness of breath, fatigue, occasional dizziness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 93% on room air

Section 1

Change in Patient Status:

As the healthcare team monitors the patient, they notice a concerning change in his status. Over the next few hours, the patient's chest pain intensifies, now rated as 8 out of 10 on the pain scale, and his shortness of breath worsens. His oxygen saturation drops further to 90% despite supplemental oxygen via nasal cannula. The patient becomes increasingly diaphoretic and pale, indicating a potential deterioration in cardiovascular function. His blood pressure has decreased to 140/90 mmHg, but his heart rate has increased to 110 bpm, suggesting compensatory tachycardia in response to decreased cardiac output.

In light of these developments, the nursing team performs a focused cardiac assessment. Auscultation reveals an S4 heart sound, indicative of decreased ventricular compliance, likely due to ischemic changes in the myocardium. Serial ECGs show new ST-segment depressions in the anterior leads, raising the suspicion of evolving myocardial ischemia. This prompts the team to consider the possibility of unstable angina, a condition that requires prompt intervention to prevent progression to myocardial infarction.

The worsening symptoms and diagnostic findings necessitate an immediate review of the patient's management plan. The healthcare team evaluates the need for urgent revascularization procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) to restore adequate blood flow. In the meantime, adjustments to the patient's medication regimen are considered, such as increasing the dose of beta-blockers or adding nitrates to relieve the acute ischemic pain. The team also discusses the importance of strict glycemic and lipid control, given the patient's history of diabetes and hyperlipidemia, to mitigate further cardiovascular risk.

Section 2

As the healthcare team implements immediate interventions based on the suspected diagnosis of unstable angina, they begin by administering sublingual nitroglycerin to alleviate the patient's chest pain and improve coronary blood flow. Despite these efforts, the patient's symptoms only marginally improve, prompting the team to re-evaluate the situation. A repeat set of laboratory tests reveals an elevated troponin level, suggesting myocardial injury and confirming the progression towards a more severe cardiac event. This biochemical evidence, coupled with the patient's unrelenting symptoms, underscores the need for urgent intervention.

The patient is swiftly prepared for a coronary angiogram to assess the extent of coronary artery blockage. During the procedure, significant stenosis is identified in the left anterior descending artery, explaining the ST-segment depressions observed on the ECG. This finding confirms the need for a percutaneous coronary intervention to restore blood flow and prevent further myocardial damage. As the team discusses the angiogram results with the patient and his family, they emphasize the critical nature of the intervention and the potential for successful outcomes with timely revascularization.

In the interim, the patient's medication regimen is adjusted to include a continuous intravenous infusion of heparin to prevent thrombus formation, along with an increased dose of beta-blockers to manage heart rate and reduce myocardial oxygen demand. The team closely monitors the patient's response to these interventions, noting a gradual stabilization of his vital signs: heart rate decreases to 95 bpm, and blood pressure stabilizes at 130/85 mmHg. The patient's oxygen saturation improves to 94% with supplemental oxygen, and he reports a reduction in chest pain to 4 out of 10. This positive response suggests that the current management strategy is effectively addressing the acute ischemic event, allowing the team to plan the next steps in his care, including possible PCI.

Section 3

As the healthcare team continues to monitor the patient, a new complication emerges, prompting further clinical evaluation. Approximately 12 hours post-angiogram, the patient begins to experience episodes of increased chest discomfort and shortness of breath. The chest pain, now rated at 7 out of 10, coincides with transient ST-segment elevations on the monitor, suggesting that the myocardial ischemia may be worsening. The team quickly re-assesses the patient, noting a slight increase in heart rate to 105 bpm and a drop in blood pressure to 110/70 mmHg. Oxygen saturation remains at 92% despite continued supplemental oxygen. These changes suggest a possible compromise in cardiac output and warrant immediate attention.

In response, the team orders a repeat set of cardiac biomarkers, which reveal an even higher elevation in troponin levels, indicating ongoing myocardial injury. Additionally, the latest ECG displays new T-wave inversions, further supporting the presence of an evolving ischemic event. The potential for acute coronary syndrome complications, such as early post-procedural restenosis or a new thrombotic event, is considered. The clinical picture necessitates a review of the patient's current anticoagulation and anti-ischemic therapies to ensure optimal management.

Given these developments, the decision is made to expedite the planned percutaneous coronary intervention (PCI). The interventional cardiologist is consulted urgently to address the potential for further coronary revascularization. The team communicates the situation to the patient and family, emphasizing the need for prompt action to mitigate the risk of a full myocardial infarction. With the patient's informed consent, preparations for the PCI proceed, highlighting the dynamic nature of cardiac care and the importance of timely interventions in the face of new complications.

Section 4

As the healthcare team prepares for the expedited percutaneous coronary intervention (PCI), they conduct a thorough initial assessment to gather baseline data and detect any further changes in the patient's condition. The patient continues to experience significant chest discomfort, now accompanied by increased diaphoresis and palpitations. The vital signs reveal a heart rate that has climbed to 115 bpm, with blood pressure now at 100/65 mmHg, indicating potential hemodynamic instability. Respiratory assessment shows that the patient is using accessory muscles to breathe, and oxygen saturation has dropped to 90%, necessitating an increase in supplemental oxygen. The physical examination also uncovers cool, clammy skin, suggesting compromised peripheral perfusion.

New diagnostic results from the repeat blood tests show a marked increase in troponin I levels, now significantly elevated from the previous measure, confirming ongoing myocardial damage. The latest ECG not only reiterates transient ST-segment elevations but also demonstrates a widening QRS complex, raising concerns about the potential development of a conduction abnormality or more extensive myocardial involvement. Furthermore, a bedside echocardiogram is performed, revealing reduced left ventricular ejection fraction and mild hypokinesis in the anterior wall, pointing to impaired cardiac function and the need for urgent intervention.

The healthcare team discusses these findings, recognizing the possibility of acute coronary syndrome progressing to a more severe state. The decision to proceed with PCI is reinforced, with the interventional cardiologist preparing to address potential coronary blockages. The team reviews and optimizes the patient's medication regimen, ensuring that antiplatelet, anticoagulant, and anti-ischemic therapies are appropriately adjusted to provide maximum protection against further ischemic events. The urgency of the situation is communicated clearly to the patient and their family, ensuring that they understand the critical nature of the next steps in the patient's care journey.

Section 5

As the healthcare team continues to monitor the patient, a change in status is noted that demands immediate attention. The patient suddenly becomes more restless and reports a sensation of impending doom, a classic symptom often associated with significant cardiac events. Concurrently, the telemetry monitor alarms, indicating further changes in cardiac rhythm. The patient's heart rate has now escalated to 130 bpm, and the blood pressure has dropped further to 90/60 mmHg, exacerbating concerns about hemodynamic instability. Oxygen saturation is persistently low at 88% despite increased supplemental oxygen, and the patient appears increasingly cyanotic with pronounced use of accessory muscles for respiration.

This acute change prompts the team to re-evaluate the current treatment plan. A repeat ECG shows further widening of the QRS complex, coupled with the appearance of frequent premature ventricular contractions (PVCs), suggesting progressive conduction abnormalities and heightened risk for arrhythmias. Given the critical nature of these findings, the decision is made to initiate intravenous antiarrhythmic therapy while preparing for urgent PCI. The patient's increasing instability underscores the importance of swift intervention to restore coronary perfusion and prevent irreversible myocardial damage.

The team communicates these developments to the patient and their family, emphasizing the acute risk of complications such as ventricular fibrillation or cardiogenic shock. They are reassured that every effort is being made to stabilize the patient's condition and minimize further cardiac injury. As the patient is prepped for the cath lab, the healthcare team remains vigilant, ready to respond to any further deterioration, and prepared to implement advanced cardiac life support measures if necessary. The next steps involve close monitoring and rapid facilitation of the PCI procedure to address the underlying coronary blockage and support myocardial recovery.